Transmutex raises over CHF 20M in extension of Series A funding

Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension of its Series A funding to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy technology. The round was led by Union Square Ventures and Steel Atlas with participation from new and existing investors including At One Ventures (USA), HCVC (France/USA) and AlleyCorp (USA), with the participation of House Of Ventures (USA), Presight Capital (USA), Verve Ventures (Switzerland), FONGIT (Switzerland) and Tiny Supercomputer Investment Co. (UK), as well as private investors. Read more